Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Mr David Lieberman

Back to Search
Lieberman DR, Mangat HK, Schmierer K ( 2022 ) . 028  Cladribine to halt deterioration in people with advanced multiple sclerosis (ChariotMS) . Journal of Neurology Neurosurgery & Psychiatry vol. 93 , ( 6 ) a22.2 - a2a22 .
Lieberman DR, Giovannoni G, Cafferty F, Bianchi L, Gnanapavan S, Marta M, Altmann DR, Kapoor R ( 2019 ) . Seamless phase II-III adaptive trial design elements for progressive MS: Neurofilament light chain (phase II/interim endpoint), phase III endpoints and patient populations . MULTIPLE SCLEROSIS JOURNAL . vol. 25 , 600 - 600 .